ARTICLE
TITLE

Results of the alcohol septal ablation in combination with simultaneous endoprosthesis of coronary arteries in treatment of patients, suffering obstructive hypertrophic cardiomyopathy and concurrent ischemic heart disease

SUMMARY

Objective. To study the immediate and remote follow-up results of treatment in patients, suffering obstructive hypertrophic cardiomyopathy and concurrent ischemic heart disease, using the alcohol septal ablation in combination with simultaneous endoprosthesis of coronary arteries.Materials and methods. In the investigation were included 129 patients, suffering obstructive hypertrophic cardiomyopathy, to whom the alcohol septal ablation was performed in 2009 - 2018 yrs in M. M. Amosov National Institute of Cardiovascular Surgery. All the patients were distributed into two groups: the first -14 (10.9%) patients with concurrent ischemic heart disease and the second -115 (89.1%) patients without concurrent ischemic heart disease.Results. Reduction of the systolic pressure gradient in the exit tract of the left ventriculus, mitral regurgitation, and the functional class characteristic in accordance to criteria of a New-York Association of Cardiologists in both groups in immediate and late periods of observation have appeared statistically proved. In a remote period of follow-up in 13 (92.9%) patients, suffering the ischemic heart disease, a satisfactory hemodynamical result was registered, and in 1 (7.1%) - poor. Conditionally poor results in this group of patients were absent. The patients without an ischemic heart disease (n=107) in accordance to the above mentioned indices were distributed in a follow manner: 74 (69.2%), 28 (26.2%) and 5 (4.7%), accordingly. Statistically significant difference in accordance to hemodynamical results between two groups of patients was absent in immediate and remote periods of follow-up.Conclusion. Simultaneous conduction of the alcohol septal ablation in combination with endoprosthesis of coronary arteries in patients, suffering obstructive hypertrophic cardiomyopathy and concurrent ischemic heart disease, constitutes a safe proved combined intervention procedure, which owes good immediate results, persisting in the remote period.

 Articles related

O. K. Gogayeva, A. V. Rudenko, V. V. Lazoryshynets    

Objective. To analyse the risk stratification effectiveness for calculators EuroSCORE I, EuroSCORE II, STS in patients with ischemic disease before cardiac surgery.Materials and methods. Retrospective analysis of data was conduct... see more


S. M. Gramatiuk, Yu. V. Ivanova, V. I. Kravchenko, O. O. Lohvinenko    

Objective. To investigate in experiment a functional state of mitochondria from the brain cells after its acute ischemic injury and processes, which take place in the brain in conditions of experimental ischemia/reperfusion; to analyze a correlation of t... see more


A. V. Gabriyelyan, S. V. Romanova    

Objective. To estimate the changes of the patients’ quality of life in those, suffering ischemic cardiomyopathy after surgical revascularization and transplantation of the stem cells, obtained from umbilical blood.Materials and methods. There was analysi... see more


?. V. Serikov, L. ?. Smirnova, G. ?. Shifrin, V. I. Dariy    

Objective. To elaborate the intensive therapy tactic in patients, suffering ischemic cerebral insult (ICI) depending on changes in the systemic hemodynamics indices and the oxygen-transportation status.??terials and methods. In 42 patients, suffering the... see more


G. B. Mankovsky    

Objective. Estimation of late results of transcutaneous coronary intervention (TCCI) in patients, suffering ?schemic heart disease (?HD) and diabetes mellitus (DM).??terials and methods. Results of questionnaires application in 459 patients were analyzed... see more